New Advisory Offers First Consensus in Prescribing GLP-1s
Anywhere from 6% to 12% of the US population has taken a GLP-1 agonist. But until now there hasn’t been a cohesive message among physicians for how to care for this growing patient population. Last month the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society released a joint advisory […]
New Advisory Offers First Consensus in Prescribing GLP-1s Read More »
